Navigation Links
Einstein and Pitt researchers develop new TB test that will dramatically cut diagnosis time
Date:3/19/2009

Besides quick diagnosis, the test also could be used to distinguish treatable TB strains from those that are drug resistant (DR-TB) and extensively drug resistant (XDR-TB), which normally takes months. Researchers treated M. tuberculosis with antibiotics at the same time the bacteriophages were introduced; the TB strains that were sensitive to antibiotics died, but the drug-resistant cells survived and continued to glow.

The study, "Fluoromycobacteriophages for Rapid, Specific, and Sensitive Antibiotic Susceptibility Testing of Mycobacterium tuberculosis," will appear in the March 19, 2009 edition of PLoS ONE.

The group's research was funded as part of a major new research initiative from Howard Hughes Medical Institute (HHMI). HHMI announced on March 19 that it will partner with University of KwaZulu-Natal in South Africa to establish an international research center focused on the TB and HIV coepidemics, called KwaZulu-Natal Research Institute for TB-HIV (K-RITH). Dr. Jacobs will direct research into developing rapid and effective TB tests, one of the new institute's primary objectives. His work with Hatfull and postdoctoral fellow Mariana Piuri on the flurophage study was related to that effort.


'/>"/>

Contact: Deirdre Branley
dbranley@aecom.yu.edu
718-430-2923
Albert Einstein College of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine
2. Einstein scientists receive $10 million NIH grant
3. Einstein researchers develop technique to count messages made by single genes
4. Einstein researchers develop a new way to study how breast cancer spreads
5. In scientific first, Einstein researchers correct decline in organ function associated with old age
6. Feinstein researchers develop new genetic method and identify novel genes for schizophrenia
7. Einstein researchers receive grants totaling $700,000 for innovative breast cancer research
8. Einstein researcher receives NIH grant to explore epigenetic regulation of the human genome
9. University researchers to develop coatings that kill superbugs
10. K-State researchers work with university in Ghana to create biofuels from native tree seeds
11. Heinz Maier-Leibnitz Prizes 2009: Six young researchers recognized for outstanding achievements

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...tudy by University of Alabama at Birmingham (UAB) ...o-existing medical conditions (co-morbidity) do no...rican-Americans compared to Caucasians who also ha.... 23 in Cancer , a journal of the American Cancer...BMI and co-morbidity are independent predictors of...
(Date:11/23/2009)...fornia biomedical engineer and cardiologist Tzung ...linicians distinguish cardiac emergencies requirin...le with drugs and lifestyle change. , Angiograms...ies feeding the heart, offer an inside view of the..., often revealing deposits of a dangerous fatty su...
(Date:11/23/2009)... , , , , , , , ..., Dr Andrew Marshall, from the Environment Depa...scovery of Kinyongia magomberae and his wider wo...r more information. , , , , ... , , , , , , A new species of ch...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 1Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 2Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 3Medicares Missing Link 3A Care Coordination and Family Caregiving by Dan Tobin M D CEO of Care Support of America 56877 4Pro Dex Inc Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast 56874 1Pro Dex Inc Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast 56874 2The 231 Stay Healthy Secret Whole Body Cleanse 28TM 29 from Enzymatic Therapy 56870 1The 231 Stay Healthy Secret Whole Body Cleanse 28TM 29 from Enzymatic Therapy 56870 2
...ersity of Delaware have uncovered a hidden weapon ...e United States uses to silently and efficiently b...hragmites australis, or common reed, believed to h...n acid so toxic that the substance literally disin...ighboring plants, thus toppling the competition. ,...
...ome analysis of a tiny green alga has uncovered hu...carbon dioxide capture and generation of biomass. ...are those that encode the structure and function o...ynthetic apparatus, the chloroplast, which is resp...The genome also provides a glimpse back through ti...
...chnology infrastructure for researching and develo...ave the industry hundreds of millions of dollars a...red by the National Institute of Standards and Tec...or NIST, the studys authors found that over the la...s shifted from small-molecule chemicals to large-m...
Other Biology News:UD plant biologists uncover top wetland plant's hidden weapon 2UD plant biologists uncover top wetland plant's hidden weapon 3Green alga genome project catalogs carbon capture machinery 2Green alga genome project catalogs carbon capture machinery 3Biopharmaceutical infrastructure key to lower drug development costs 2
(Date:11/24/2009)...stCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiopharmac...gnovelpainmanagementtherapies,announcedtodaythatAn...cheduledtopresentatthe21stAnnualPiperJaffrayHealth...kPalaceHotelinNewYork,NewYork. ,, Mr.DiTonnoand...abletorespondtoquestionsduringthepresentationsandt...
(Date:11/24/2009)...atientswithadvanced-stage,orrecurrentendometrialca...l/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(the"...endocrinetherapyandoncology,todayannouncedpositive...icpeptideconjugate,AEZS-108(formerlyAN-152),inpati...rsonalizedhealthcareapproach,thestudyselectedpatie...
(Date:11/24/2009)...FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )today...airman,willpresentatthe21stAnnualPiperJaffrayHealt...09at10:00a.m.ET. ,, Toaccesstheliveandsubsequen...orRelationssectionofGenomicHealth,swebsiteat http:...bsiteatleast15minutespriortothebeginningoftheprese...
(Date:11/24/2009)...-CellTherapeutics,Inc.(CTI)(NasdaqandMTA:CTIC)mana...CareConference.TheconferencewillbeheldDecember1-2,...onTuesday,December1at11:00a.m.EasternTimeinHolmes1...lbeavailableat www.celltherapeutics.com ,anditwill...ayHealthCareConference,NewYorkPalaceHotel,Holmes1(...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
... Eiger BioPharmaceuticals, Inc.,a start-up biotec...nounced,that it has raised $7.1 million in a Serie...o Ventures. The two firms were instrumental in the...eam and are represented on the board of,directors ...gelman,respectively. The funding will advance the...
...-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NAS...ceutical and medical device company, today announc...d conference call. The call will take place at 10:..., , , Dial information for the earnings call o...ows:, North America (toll-free): (800) 291-9234...
... An investor group in Trinity,Biotech plc (Nasdaq:...er of,diagnostic products, has petitioned the Offi...ilitate compliance with key company law provisions...ders and prospective shareholders. , The petit...directors,Peter Coyne of Allied Irish Bank, and Dr...
Other Biology Technology:Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round 2
Anti-4-hydroxy-2-hexenal Monoclonal Antibody, Unconjugated from Cosmo Bio Co., Ltd.
Anti-Human VEGFR-2 / KDR Antibody, Unconjugated from Cell Sciences
Rabbit Anti-Human Tankyrase 2 (TNKL (TNKS2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
...olved in translation initiation. PHAS-II is highes...E, the mRNA cap-binding protein, and inhibit trans...horylation in the appropriate site(s) promotes dis...F-4E to bind to eIF-4G (p220), thereby increasing ...
Biology Products: